No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia

Magnesium Research

Volumn 27, Issue 2, 2014, Pages 48-56

  Navarrete Cortes, Adrian ^a   Ble Castillo, Jorge L ^b   Guerrero Romero, Fernando ^c   Cordova Uscanga, Ruben ^b   Juárez Rojop, Isela E ^b   Aguilar Mariscal, Hidemi ^b   Tovilla Zarate, Carlos Alfonso ^d   Lopez Guevara, Maria del Rocio ^a  

^a Hospital General de Zona IMSS   (Mexico)

^b UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d División Académica Multidisciplinaria de Comalcalco   (Mexico)

Author keywords

Diabetes mellitus; Insulin sensitivity; Magnesium; Metabolic control

Indexed keywords

CREATININE; HEMOGLOBIN A1C; MAGNESIUM; MAGNESIUM LACTATE; PLACEBO; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY SURFACE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MAGNESIUM EXCRETION; MAGNESIUM SUPPLEMENTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT OUTCOME; BLOOD; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNESIUM; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84907150834     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2014.0361     Document Type: Article

References (28)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378: 31-40.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
4. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-21.
5. The Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med 2002; 346: 393-403.
6. Andrews RC, Cooper AR, Montgomery AA, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet 2011; 378: 129-39.
7. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004; 17: 126-36.
8. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007; 262: 208-14.
9. Dong J-Y, Xun P, He K, Qin L-Q. Magnesium Intake and Risk of Type 2 Diabetes: Metaanalysis of prospective cohort studies. Diabetes Care 2011; 34: 2116-22.
10. Hata A, Doi Y, Ninomiya T, et al. Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. Diabet Med 2013; 30: 1487-94.
11. Nanri A, Mizoue T, Noda M, et al. Magnesium intake and type II diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Eur J Clin Nutr 2010; 64: 1244-7.
12. Gunther T. The biochemical function of Mg(2)+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res 2010; 23: 5-18.
13. Guerrero-Romero F, Tamez-Perez HE, González-González G, et al. Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004; 30: 253-8.
14. Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-4.
15. de Valk HW, Verkaaik R, van Rijn HJM, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 1998; 15: 503-7.
16. Gullestad L, Jacobsen T, Dolva LO. Effect of Magnesium Treatment on Glycemic Control and Metabolic Parameters in NIDDM Patients. Diabetes Care 1994; 17: 460-1.
17. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006; 23: 1050-6.
18. Mejía-Rodríguez F, Shamah-Levy T, Villalpando S, García-Guerra A, Méndez-Gómez Humarán I. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013; 55: 275-84.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
20. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
21. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D’Onofrio F. Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects. Diabetes Care 1989; 12: 265-9.
22. Corica F, Allegra A, Di Benedetto A, et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with noninsulin-dependent diabetes mellitus. Magnes Res 1994; 7: 43-7.
23. Saris N-EL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A, Magnesium: A. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
24. Pham P-CT, Pham P-MT, Pham SV, Miller JM, Pham P-TT. Hypomagnesemia in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol 2007; 2: 366-73.
25. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012; 16: 1000-3.
26. Meisel P, Schwahn C, Luedemann J, John U, Kroemer HK, Kocher T. Magnesium Deficiency is Associated with Periodontal Disease. J Dent Res 2005; 84: 937-41.
27. Dimai H-P, Porta S, Wirnsberger G, et al. Daily Oral Magnesium Supplementation Suppresses Bone Turnover in Young Adult Males. J Clin Endocrinol Metab 1998; 83: 2742-8.
28. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res 2001; 14: 257-62.